Plain-English translation of NCT06803368 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is for people who have successfully completed interferon treatment for chronic hepatitis B and achieved a strong response. Researchers want to see whether giving a hepatitis B vaccine booster helps people stay protected long-term, and they'll track your immune system and liver health over time to find the best way to maintain your recovery.
After successful hepatitis B treatment, some people's immune protection gradually weakens. This study aims to find out whether booster vaccinations can strengthen and maintain that protection, and what happens to people's virus markers and liver health without treatment.
You likely qualify if…
You likely don't qualify if…
You will be placed into one of three groups based on your baseline immune protection level. Depending on your group, you may receive three booster vaccine injections (or no vaccine if your immune protection is already strong), and all participants will visit the clinic every 3–6 months for blood tests, imaging studies, and liver health checks. The study tracks your liver function, virus levels, and immune response over an extended follow-up period.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China